↓ Skip to main content

Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database

Overview of attention for article published in Frontiers in Pharmacology, April 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
2 news outlets
twitter
2 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database
Published in
Frontiers in Pharmacology, April 2022
DOI 10.3389/fphar.2022.891336
Pubmed ID
Authors

Zhi-Xuan Zhou, Xue-Dong Yin, Yu Zhang, Qi-Hui Shao, Xin-Yu Mao, Wen-Juan Hu, Yun-Lin Shen, Bin Zhao, Zhi-Ling Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 16%
Unspecified 2 8%
Student > Bachelor 2 8%
Student > Doctoral Student 2 8%
Student > Master 2 8%
Other 0 0%
Unknown 13 52%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 5 20%
Unspecified 2 8%
Medicine and Dentistry 2 8%
Agricultural and Biological Sciences 1 4%
Unknown 15 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 May 2023.
All research outputs
#1,839,332
of 23,666,107 outputs
Outputs from Frontiers in Pharmacology
#676
of 17,276 outputs
Outputs of similar age
#42,584
of 444,923 outputs
Outputs of similar age from Frontiers in Pharmacology
#33
of 1,226 outputs
Altmetric has tracked 23,666,107 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,276 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 1,226 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.